Snapshot from Jul 05, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Glucosamine
Other

Glucosamine

Tracked across 1 events · 20 articles · First seen Jun 09, 2026 · Last active Jun 11, 2026

Sentiment
-70
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
6 -70
Tech
Glucosamine Linked to Alzheimer's Progression
Impact: Glucosamine, a widely used over-the-counter supplement for joint pain, has been associated with a higher likelihood of progression from mild cognitive impairment to Alzheimer s disease and increased mortality risk in Alzheimer's patients. This research suggests its use may worsen neurodegenerative decline.
Jun 09, 2026 · 20 articles
NEWSDESK
Track Glucosamine live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.